Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1985-10-28
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0039-2499
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
899-900
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3901426-Cerebrovascular Disorders,
pubmed-meshheading:3901426-Clinical Trials as Topic,
pubmed-meshheading:3901426-Double-Blind Method,
pubmed-meshheading:3901426-Female,
pubmed-meshheading:3901426-G(M1) Ganglioside,
pubmed-meshheading:3901426-Humans,
pubmed-meshheading:3901426-Male,
pubmed-meshheading:3901426-Middle Aged
|
pubmed:articleTitle |
Monosialoganglioside therapy in stroke.
|
pubmed:publicationType |
Letter,
Clinical Trial
|